These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 2122131)
21. Multicentre randomised study of adjuvant chemotherapy with mitomycin C and tegafur or tegafur-uracil in gastric cancer. Arima S; Ohsato K; Hisatsugu T; Shimura H Eur J Surg; 1994 Apr; 160(4):227-32. PubMed ID: 8049313 [TBL] [Abstract][Full Text] [Related]
22. Postoperative adjuvant immunochemotherapy and infiltration of dendritic cells for patients with advanced gastric cancer. Tsujitani S; Kakeji Y; Orita H; Watanabe A; Kohnoe S; Baba H; Anai H; Maehara Y; Sugimachi K Anticancer Res; 1992; 12(3):645-8. PubMed ID: 1622120 [TBL] [Abstract][Full Text] [Related]
23. [Comparison of immunochemotherapy and chemotherapy of stage IV gastric carcinoma]. Kanabe S; Tamakuma S; Mimura K; Hiraide H; Mochizuki H; Tamaki K; Kurokawa T; Kadota T; Hatsuse K; Kawano M Gan No Rinsho; 1985 Nov; 31(14):1805-9. PubMed ID: 3936946 [TBL] [Abstract][Full Text] [Related]
24. [Prospective randomized controlled study of bestatin in gastric cancer surgery]. Yoshinaka K; Tanaka T; Takagami S; Saeki T; Nishiyama M; Toge T; Niimoto M; Hattori T Gan To Kagaku Ryoho; 1988 Mar; 15(3):493-8. PubMed ID: 3126708 [TBL] [Abstract][Full Text] [Related]
25. A case of advanced gastric cancer with long-term survival as the results of combined radiation therapy and chemotherapy. Tsukiyama I; Watai K; Yanagawa S; Akine Y; Ono R; Egawa S; Hirota T; Yoshida S; Yamaguchi H; Ushio K Jpn J Clin Oncol; 1986 Jun; 16(2):157-66. PubMed ID: 3090315 [TBL] [Abstract][Full Text] [Related]
26. [Effect of adjuvant chemotherapy for patients with early gastric cancer]. Sasaki A; Furusawa M; Tomoda H; Seo Y; Ohno S; Matsukuma A; Morita M; Kakeji Y Gan To Kagaku Ryoho; 1994 Jan; 21(1):37-45. PubMed ID: 8291914 [TBL] [Abstract][Full Text] [Related]
27. [Postoperative adjuvant chemotherapy using NCS (neocarzinostatin) and 5-FU in the treatment of gastric cancer. First report--A comparison with the 5-year survival rate of patients undergoing combined therapy with MMC and 5-FU]. Yokomori T; Taniguchi T; Iesato H; Sakata Y; Watanabe T; Kawabe K Gan To Kagaku Ryoho; 1987 Nov; 14(11):3064-70. PubMed ID: 2960267 [TBL] [Abstract][Full Text] [Related]
28. 5-Fluorouracil, mitomycin-c, and polysaccharide-k versus uracil-ftorafur and polysaccharide-K as adjuvant chemoimmunotherapy for patients with locally advanced gastric cancer with curative resection. Ahn MS; Kang SY; Lee HW; Jeong SH; Park JS; Lee KJ; Cho YK; Han SU; Lee SY; Lim HY; Choi JH Onkologie; 2013; 36(7-8):421-6. PubMed ID: 23921761 [TBL] [Abstract][Full Text] [Related]
29. Randomized trial of adjuvant chemotherapy with mitomycin plus ftorafur versus mitomycin alone in resected locally advanced gastric cancer. Grau JJ; Estapé J; Fuster J; Filella X; Visa J; Terés J; Soler G; Albiol S; García-Valdecasas JC; Grande L; Bombí J; Bordas J; Alcobendas F J Clin Oncol; 1998 Mar; 16(3):1036-9. PubMed ID: 9508188 [TBL] [Abstract][Full Text] [Related]
30. Combined effect of prophylactic lymphadenectomy and long term combination chemotherapy for curatively resected carcinoma of the stomach. Kodama Y; Kano T; Tamada R; Kumashiro R; Okamura T; Inokuchi K Jpn J Surg; 1982; 12(4):244-8. PubMed ID: 6811786 [TBL] [Abstract][Full Text] [Related]
31. [Randomized study on the long-term adjuvant chemotherapy with ftorafur and mitomycin C for stomach cancer: second report]. Abe O; Inokuchi K; Hattori T; Inoue K; Taguchi T; Kondo T; Akiyama H; Ito I; Nakajima T; Muto T Gan To Kagaku Ryoho; 1983 Nov; 10(11):2408-17. PubMed ID: 6416184 [TBL] [Abstract][Full Text] [Related]
32. [Cooperative studies on surgical adjuvant immunochemotherapy for prevention of postoperative recurrence of gastric cancer]. Imaizumi M; Kondo T; Kamei H; Ichihashi H Gan To Kagaku Ryoho; 1984 Jan; 11(1):60-8. PubMed ID: 6421243 [TBL] [Abstract][Full Text] [Related]
33. [Adjuvant chemotherapy for aged patients with gastric carcinoma]. Kano T; Notsuka T; Hiramoto Y; Abe Y; Masuda H; Kumashiro R; Inokuchi K Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt):278-82. PubMed ID: 6410995 [TBL] [Abstract][Full Text] [Related]
34. [A randomized controlled trial of surgical adjuvant therapy with mitomycin C, 5-fluorouracil and OK-432 in patients with gastric cancer]. Yamamura Y; Nishimura M; Sakamoto J; Yasui K; Morimoto T; Kato T; Yasue M; Kito T; Miyaishi S; Nakazato H Gan To Kagaku Ryoho; 1986 Jun; 13(6):2134-40. PubMed ID: 3087293 [TBL] [Abstract][Full Text] [Related]
35. Late results of postoperative long term cancer chemotherapy for advanced carcinoma of the stomach. Kano T; Kumashiro R; Tamada R; Kodama Y; Inokuchi K Jpn J Surg; 1981; 11(4):291-6. PubMed ID: 6793759 [TBL] [Abstract][Full Text] [Related]
36. Ten-year survival of curability B gastric cancer patients treated by tegafur-uracil as postoperative adjuvant chemotherapy in a common public hospital: univariate and multivariate analyses. Okuyama T; Higashi T; Edagawa A; Nagata S; Hashimoto K; Saeki H; Oki E; Uchiyama H; Kawanaka H; Morita M; Tateishi M; Korenaga D; Yaita H; Takenaka K Fukuoka Igaku Zasshi; 2012 Jul; 103(7):138-44. PubMed ID: 22978066 [TBL] [Abstract][Full Text] [Related]
37. [A randomized controlled trial comparing short-term MF chemotherapy with MF plus long-term HCFU chemotherapy as an adjuvant to a curative resection of stomach cancer: Mifurol Study Group for Stomach Cancer]. Yamamura Y; Nakazato H; Koike A; Ichihashi H Gan No Rinsho; 1988 Nov; 34(14):1936-42. PubMed ID: 3144615 [TBL] [Abstract][Full Text] [Related]
38. [Effect of levamisole in postoperative adjuvant immunochemotherapy of stomach cancer--randomized controlled study of MMC-tegafur combination therapy with or without levamisole. 1]. Niimoto M; Hattori T; Itoh I; Tamada R; Inokuchi K; Orita K; Furue H; Ogawa N; Toda T; Furusawa M; Koga S; Hashimoto I; Kondo T; Fujimoto S; Sugiyama Y; Abe O; Ohya M Gan To Kagaku Ryoho; 1982 Dec; 9(12):2133-47. PubMed ID: 6820890 [TBL] [Abstract][Full Text] [Related]
39. Lymph-node ratio is an important clinical determinant for selecting the appropriate adjuvant chemotherapy regimen for curative D2-resected gastric cancer. Hwang JE; Kim H; Shim HJ; Bae WK; Hwang EC; Jeong O; Ryu SY; Park YK; Cho SH; Chung IJ J Cancer Res Clin Oncol; 2019 Aug; 145(8):2157-2166. PubMed ID: 31273512 [TBL] [Abstract][Full Text] [Related]
40. Postoperative adjuvant randomised trial comparing chemoendocrine therapy, chemotherapy and immunotherapy for patients with stage II breast cancer: 5-year results from the Nishinihon Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer (ACETBC) of Japan. Morimoto T; Ogawa M; Orita K; Sugimachi K; Toge T; Dohi K; Nomura Y; Monden Y; Ogawa N Eur J Cancer; 1996 Feb; 32A(2):235-42. PubMed ID: 8664034 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]